|
|
||||||||
Department of Pharmacology, New York Medical College, Valhalla, New York
20-HETE, a potent vasoconstrictor, is
generated by cytochrome P-450
-hydroxylases and is the
principal eicosanoid produced by preglomerular microvessels. It is
released from preglomerular microvessels by ANG II and is subject to
metabolism by cyclooxygenase (COX). Because low-salt (LS) intake
stimulates the renin-angiotensin system and induces renal cortical
COX-2 expression, we examined 20-HETE release from renal arteries
(interlobar and arcuate and interlobular arteries) obtained from 6- to
7-wk-old male Sprague-Dawley rats fed either normal salt (0.4% NaCl)
or LS (0.05% NaCl) diets for 10 days. With normal salt intake, the
levels of 20-HETE recovered were similar in arcuate and interlobular
arteries and interlobar arteries: 30.1 ± 8.5 vs. 24.6 ± 5.3 ng · mg
protein
1 · 30 min
1,
respectively. An LS diet increased 20-HETE levels in the incubate of
either arcuate and interlobular or interlobar renal arteries only when
COX was inhibited. Addition of indomethacin (10 µM) to the incubate
of arteries obtained from rats fed an LS diet resulted in a two- to
threefold increase in 20-HETE release from arcuate and interlobular
arteries, from 39.1 ± 13.2 to 101.8 ± 42.6 ng · mg
protein
1 · 30 min
1
(P < 0.03), and interlobar arteries, from 31.7 ± 15.1 to 61.9 ± 29.4 ng · mg
protein
1 · 30 min
1
(P < 0.05) compared with release of 20-HETE when COX
was not inhibited. An LS diet enhanced vascular expression of
cytochrome P-4504A and COX-2 in arcuate and interlobular
arteries; COX-1 was unaffected. Metabolism of 20-HETE by COX is
proposed to represent an important regulatory mechanism in setting
preglomerular microvascular tone.
renal microvessels; salt depletion; eicosanoids; cytochrome P-450
This article has been cited by other articles:
![]() |
Y.-J. Chen, J. Li, and J. Quilley Deficient renal 20-HETE release in the diabetic rat is not the result of oxidative stress Am J Physiol Heart Circ Physiol, May 1, 2008; 294(5): H2305 - H2312. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Minuz, H. Jiang, C. Fava, L. Turolo, S. Tacconelli, M. Ricci, P. Patrignani, A. Morganti, A. Lechi, and J. C. McGiff Altered Release of Cytochrome P450 Metabolites of Arachidonic Acid in Renovascular Disease Hypertension, May 1, 2008; 51(5): 1379 - 1385. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Fang, F. M. Faraci, T. L. Kaduce, S. Harmon, M. L. Modrick, S. Hu, S. A. Moore, J. R. Falck, N. L. Weintraub, and A. A. Spector 20-Hydroxyeicosatetraenoic acid is a potent dilator of mouse basilar artery: role of cyclooxygenase Am J Physiol Heart Circ Physiol, November 1, 2006; 291(5): H2301 - H2307. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Joly, R. Seqqat, B. Flamion, N. Caron, A. Michel, J. D. Imig, and R. Kramp Increased renal vascular reactivity to ANG II after unilateral nephrectomy in the rat involves 20-HETE Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2006; 291(4): R977 - R986. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Carroll, A. B. Doumad, J. Li, M. K. Cheng, J. R. Falck, and J. C. McGiff Adenosine2A receptor vasodilation of rat preglomerular microvessels is mediated by EETs that activate the cAMP/PKA pathway Am J Physiol Renal Physiol, July 1, 2006; 291(1): F155 - F161. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. L. Liclican, J. C. McGiff, P. L. Pedraza, N. R. Ferreri, J. R. Falck, and M. A. Carroll Exaggerated response to adenosine in kidneys from high salt-fed rats: role of epoxyeicosatrienoic acids Am J Physiol Renal Physiol, August 1, 2005; 289(2): F386 - F392. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Imig 20-HETE or EETs: which arachidonic acid metabolite regulates proximal tubule transporters and contributes to pressure natriuresis? Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2004; 287(1): R3 - R5. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |